Hallmarks of Cancer: New Dimensions

Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9

Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013

Yuan, 2019, Cellular plasticity in cancer, Cancer Discov, 9, 837, 10.1158/2159-8290.CD-19-0015

Barker, 2009, Crypt stem cells as the cells-of-origin of intestinal cancer, Nature, 457, 608, 10.1038/nature07602

Perekatt, 2018, SMAD4 suppresses WNT-driven dedifferentiation and oncogenesis in the differentiated gut epithelium, Cancer Res, 78, 4878, 10.1158/0008-5472.CAN-18-0043

Shih, 2001, Top-down morphogenesis of colorectal tumors, Proc Natl Acad Sci U S A, 98, 2640, 10.1073/pnas.051629398

Ordóñez-Morán, 2015, HOXA5 counteracts stem cell traits by inhibiting Wnt signaling in colorectal cancer, Cancer Cell, 28, 815, 10.1016/j.ccell.2015.11.001

Tan, 2015, Stemming colorectal cancer growth and metastasis: HOXA5 forces cancer stem cells to differentiate, Cancer Cell, 28, 683, 10.1016/j.ccell.2015.11.004

Köhler, 2017, Mouse cutaneous melanoma induced by mutant BRaf arises from expansion and dedifferentiation of mature pigmented melanocytes, Cell Stem Cell, 21, 679, 10.1016/j.stem.2017.08.003

Shah, 2010, A role for ATF2 in regulating MITF and melanoma development, PLoS Genet, 6, e1001258, 10.1371/journal.pgen.1001258

Claps, 2016, A transcriptionally inactive ATF2 variant drives melanomagenesis, Cell Rep, 15, 1884, 10.1016/j.celrep.2016.04.072

Saghafinia, 2021, Cancer cells retrace a stepwise differentiation program during malignant progression, Cancer Discov, 11, 2638, 10.1158/2159-8290.CD-20-1637

Yu, 2019, Defining multistep cell fate decision pathways during pancreatic development at single-cell resolution, EMBO J, 38, e100164, 10.15252/embj.2018100164

de Thé, 2018, Differentiation therapy revisited, Nat Rev Cancer, 18, 117, 10.1038/nrc.2017.103

He, 1999, In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications, Oncogene, 18, 5278, 10.1038/sj.onc.1203088

Warrell, 1993, Acute promyelocytic leukemia, N Engl J Med, 329, 177, 10.1056/NEJM199307153290307

Bots, 2014, Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors, Blood, 123, 1341, 10.1182/blood-2013-03-488114

Ferrara, 2001, Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia, Cancer Res, 61, 2

Kaufman, 2016, A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation, Science, 351, aad2197, 10.1126/science.aad2197

Morris, 2019, α-Ketoglutarate links p53 to cell fate during tumour suppression, Nature, 573, 595, 10.1038/s41586-019-1577-5

Saha, 2014, Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer, Nature, 513, 110, 10.1038/nature13441

Dang, 2017, Isocitrate dehydrogenase mutation and (R)-2-hydroxyglutarate: from basic discovery to therapeutics development, Annu Rev Biochem, 86, 305, 10.1146/annurev-biochem-061516-044732

Waitkus, 2018, Biological role and therapeutic potential of IDH mutations in cancer, Cancer Cell, 34, 186, 10.1016/j.ccell.2018.04.011

Phan, 2020, The dormant cancer cell life cycle, Nat Rev Cancer, 20, 398, 10.1038/s41568-020-0263-0

Jiang, 2016, MIST1 and PTF1 collaborate in feed-forward regulatory loops that maintain the pancreatic acinar phenotype in adult mice, Mol Cell Biol, 36, 2945, 10.1128/MCB.00370-16

Krah, 2019, Prevention and reversion of pancreatic tumorigenesis through a differentiation-based mechanism, Dev Cell, 50, 744, 10.1016/j.devcel.2019.07.012

Krah, 2015, The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma, eLife, 4, e07125, 10.7554/eLife.07125

Shi, 2013, Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia, Oncogene, 32, 1950, 10.1038/onc.2012.210

Kopp, 2012, Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma, Cancer Cell, 22, 737, 10.1016/j.ccr.2012.10.025

Julian, 2017, Direct reprogramming with SOX factors: masters of cell fate, Curr Opin Genet Dev, 46, 24, 10.1016/j.gde.2017.06.005

Grimm, 2020, The role of SOX family members in solid tumours and metastasis, Semin Cancer Biol, 67, 122, 10.1016/j.semcancer.2019.03.004

Mu, 2017, SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer, Science, 355, 84, 10.1126/science.aah4307

Von Hoff, 2009, Inhibition of the hedgehog pathway in advanced basal-cell carcinoma, N Engl J Med, 361, 1164, 10.1056/NEJMoa0905360

Biehs, 2018, A cell identity switch allows residual BCC to survive Hedgehog pathway inhibition, Nature, 562, 429, 10.1038/s41586-018-0596-y

Boumahdi, 2020, The great escape: tumour cell plasticity in resistance to targeted therapy, Nat Rev Drug Discov, 19, 39, 10.1038/s41573-019-0044-1

Groves, 2021, Cancer Hallmarks Define a Continuum of Plastic Cell States between Small Cell Lung Cancer Archetypes [Internet]

LaFave, 2020, Epigenomic state transitions characterize tumor progression in mouse lung adenocarcinoma, Cancer Cell, 38, 212, 10.1016/j.ccell.2020.06.006

Marjanovic, 2020, Emergence of a high-plasticity cell state during lung cancer evolution, Cancer Cell, 38, 229, 10.1016/j.ccell.2020.06.012

Drapkin, 2020, Studying lineage plasticity one cell at a time, Cancer Cell, 38, 150, 10.1016/j.ccell.2020.07.001

Inoue, 2020, Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer [Internet]

Dravis, 2018, Epigenetic and transcriptomic profiling of mammary gland development and tumor models disclose regulators of cell state plasticity, Cancer Cell, 34, 466, 10.1016/j.ccell.2018.08.001

Malta, 2018, Machine learning identifies stemness features associated with oncogenic dedifferentiation, Cell, 173, 338, 10.1016/j.cell.2018.03.034

Miao, 2020, A dedicated evolutionarily conserved molecular network licenses differentiated cells to return to the cell cycle, Dev Cell, 55, 178, 10.1016/j.devcel.2020.07.005

De Blander, 2021, Cellular plasticity: a route to senescence exit and tumorigenesis, Cancers, 13, 4561, 10.3390/cancers13184561

Merrell, 2016, Adult cell plasticity in vivo: de-differentiation and transdifferentiation are back in style, Nat Rev Mol Cell Biol, 17, 413, 10.1038/nrm.2016.24

Baylin, 2016, Epigenetic determinants of cancer, Cold Spring Harb Perspect Biol, 8, a019505, 10.1101/cshperspect.a019505

Flavahan, 2017, Epigenetic plasticity and the hallmarks of cancer, Science, 357, eaal2380, 10.1126/science.aal2380

Jones, 2016, Targeting the cancer epigenome for therapy, Nat Rev Genet, 17, 630, 10.1038/nrg.2016.93

Huang, 2012, Tumor progression: Chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution, Prog Biophys Mol Biol, 110, 69, 10.1016/j.pbiomolbio.2012.05.001

Darwiche, 2020, Epigenetic mechanisms and the hallmarks of cancer: an intimate affair, Am J Cancer Res, 10, 1954

Feng, 2021, 3D chromatin architecture and epigenetic regulation in cancer stem cells, Protein Cell, 12, 440, 10.1007/s13238-020-00819-2

Nam, 2021, Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics, Nat Rev Genet, 22, 3, 10.1038/s41576-020-0265-5

Bitman-Lotan, 2021, Nuclear organization and regulation of the differentiated state, Cell Mol Life Sci CMLS, 78, 3141, 10.1007/s00018-020-03731-4

Goldberg, 2007, Epigenetics: a landscape takes shape, Cell, 128, 635, 10.1016/j.cell.2007.02.006

Zeng, 2019, DNA methylation reprogramming during mammalian development, Genes, 10, 257, 10.3390/genes10040257

Hegde, 2019, Recent developments in transcriptional and translational regulation underlying long-term synaptic plasticity and memory, Learn Mem, 26, 307, 10.1101/lm.048769.118

Kim, 2017, Epigenetic regulation and chromatin remodeling in learning and memory, Exp Mol Med, 49, e281, 10.1038/emm.2016.140

Thienpont, 2016, Tumors smother their epigenome, Mol Cell Oncol, 3, e1240549, 10.1080/23723556.2016.1240549

Gameiro, 2018, Nutrient deprivation elicits a transcriptional and translational inflammatory response coupled to decreased protein synthesis, Cell Rep, 24, 1415, 10.1016/j.celrep.2018.07.021

Lin, 2020, Understanding the deadly silence of posterior fossa A ependymoma, Mol Cell, 78, 999, 10.1016/j.molcel.2020.05.020

Michealraj, 2020, Metabolic regulation of the epigenome drives lethal infantile ependymoma, Cell, 181, 1329, 10.1016/j.cell.2020.04.047

Bakir, 2020, EMT, MET, plasticity, and tumor metastasis, Trends Cell Biol, 30, 764, 10.1016/j.tcb.2020.07.003

Gupta, 2019, Phenotypic plasticity: driver of cancer initiation, progression, and therapy resistance, Cell Stem Cell, 24, 65, 10.1016/j.stem.2018.11.011

Lambert, 2021, Linking EMT programmes to normal and neoplastic epithelial stem cells, Nat Rev Cancer, 21, 325, 10.1038/s41568-021-00332-6

Lindner, 2020, EMT transcription factor ZEB1 alters the epigenetic landscape of colorectal cancer cells, Cell Death Dis, 11, 147, 10.1038/s41419-020-2340-4

Javaid, 2013, Dynamic chromatin modification sustains epithelial-mesenchymal transition following inducible expression of Snail-1, Cell Rep, 5, 1679, 10.1016/j.celrep.2013.11.034

Serrano-Gomez, 2016, Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications, Mol Cancer, 15, 18, 10.1186/s12943-016-0502-x

Skrypek, 2017, Epithelial-to-mesenchymal transition: epigenetic reprogramming driving cellular plasticity, Trends Genet TIG, 33, 943, 10.1016/j.tig.2017.08.004

Li, 2013, Hijacking the neuronal NMDAR signaling circuit to promote tumor growth and invasion, Cell, 153, 86, 10.1016/j.cell.2013.02.051

Li, 2018, GKAP acts as a genetic modulator of NMDAR signaling to govern invasive tumor growth, Cancer Cell, 33, 736, 10.1016/j.ccell.2018.02.011

Mohammadi, 2018, Mechanisms and impact of altered tumour mechanics, Nat Cell Biol, 20, 766, 10.1038/s41556-018-0131-2

Odenthal, 2016, Plasticity of tumor cell invasion: governance by growth factors and cytokines, Carcinogenesis, 37, 1117

Torres, 2016, The linker histone H1.0 generates epigenetic and functional intratumor heterogeneity, Science, 353, aaf1644, 10.1126/science.aaf1644

Puram, 2017, Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer, Cell, 171, 1611, 10.1016/j.cell.2017.10.044

Kinker, 2020, Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity, Nat Genet, 52, 1208, 10.1038/s41588-020-00726-6

Murtha, 2016, Extraordinary cancer epigenomics: thinking outside the classical coding and promoter box, Trends Cancer, 2, 572, 10.1016/j.trecan.2016.08.004

Nebbioso, 2018, Cancer epigenetics: moving forward, PLoS Genet, 14, e1007362, 10.1371/journal.pgen.1007362

Tavernari, 2021, Non-genetic evolution drives lung adenocarcinoma spatial heterogeneity and progression, Cancer Discov, 11, 1490, 10.1158/2159-8290.CD-20-1274

Heyn, 2016, Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer, Genome Biol, 17, 11, 10.1186/s13059-016-0879-2

Saghafinia, 2018, Pan-cancer landscape of aberrant DNA methylation across human tumors, Cell Rep, 25, 1066, 10.1016/j.celrep.2018.09.082

Audia, 2016, Histone modifications and cancer, Cold Spring Harb Perspect Biol, 8, a019521, 10.1101/cshperspect.a019521

Corces, 2018, The chromatin accessibility landscape of primary human cancers, Science, 362, eaav1898, 10.1126/science.aav1898

Esteve-Puig, 2020, Writers, readers and erasers of RNA modifications in cancer, Cancer Lett, 474, 127, 10.1016/j.canlet.2020.01.021

Janin, 2020, Disruption of the RNA modifications that target the ribosome translation machinery in human cancer, Mol Cancer, 19, 70, 10.1186/s12943-020-01192-8

Hanahan, 2012, Accessories to the crime: functions of cells recruited to the tumor microenvironment, Cancer Cell, 21, 309, 10.1016/j.ccr.2012.02.022

Lu, 2020, Epigenetic therapy inhibits metastases by disrupting premetastatic niches, Nature, 579, 284, 10.1038/s41586-020-2054-x

Thomas, 2017, The host microbiome regulates and maintains human health: a primer and perspective for non-microbiologists, Cancer Res, 77, 1783, 10.1158/0008-5472.CAN-16-2929

Dzutsev, 2017, Microbes and cancer, Annu Rev Immunol, 35, 199, 10.1146/annurev-immunol-051116-052133

Helmink, 2019, The microbiome, cancer, and cancer therapy, Nat Med, 25, 377, 10.1038/s41591-019-0377-7

Sears, 2014, Microbes, microbiota, and colon cancer, Cell Host Microbe, 15, 317, 10.1016/j.chom.2014.02.007

Pleguezuelos-Manzano, 2020, Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli, Nature, 580, 269, 10.1038/s41586-020-2080-8

Okumura, 2021, Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion, Nat Commun, 12, 5674, 10.1038/s41467-021-25965-x

Salvi, 2021, Butyrate and the intestinal epithelium: modulation of proliferation and inflammation in homeostasis and disease, Cells, 10, 1775, 10.3390/cells10071775

Fessler, 2019, Exploring the emerging role of the microbiome in cancer immunotherapy, J Immunother Cancer, 7, 108, 10.1186/s40425-019-0574-4

Gopalakrishnan, 2018, The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy, Cancer Cell, 33, 570, 10.1016/j.ccell.2018.03.015

Zitvogel, 2018, The microbiome in cancer immunotherapy: diagnostic tools and therapeutic strategies, Science, 359, 1366, 10.1126/science.aar6918

Baruch, 2021, Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients, Science, 371, 602, 10.1126/science.abb5920

Davar, 2021, Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients, Science, 371, 595, 10.1126/science.abf3363

Griffin, 2021, Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy, Science, 373, 1040, 10.1126/science.abc9113

Mager, 2020, Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy, Science, 369, 1481, 10.1126/science.abc3421

Ansaldo, 2021, How microbiota improve immunotherapy, Science, 373, 966, 10.1126/science.abl3656

Ansaldo, 2021, Control of immunity by the microbiota, Annu Rev Immunol, 39, 449, 10.1146/annurev-immunol-093019-112348

Zhang, 2021, Gut microbiome directs hepatocytes to recruit MDSCs and promote cholangiocarcinoma, Cancer Discov, 11, 1248, 10.1158/2159-8290.CD-20-0304

Ding, 2014, Dynamics and associations of microbial community types across the human body, Nature, 509, 357, 10.1038/nature13178

Byrd, 2021, Gut microbiome stability and dynamics in healthy donors and patients with non-gastrointestinal cancers, J Exp Med, 218, e20200606, 10.1084/jem.20200606

Healy, 2019, The microbiome and oral cancer: more questions than answers, Oral Oncol, 89, 30, 10.1016/j.oraloncology.2018.12.003

Swaney, 2021, Living in your skin: microbes, molecules and mechanisms, Infect Immun, 89, e00695, 10.1128/IAI.00695-20

Willis, 2020, The human oral microbiome in health and disease: from sequences to ecosystems, Microorganisms, 8, 308, 10.3390/microorganisms8020308

Xu, 2020, Vaginal microbiomes and ovarian cancer: a review, Am J Cancer Res, 10, 743

Nejman, 2020, The human tumor microbiome is composed of tumor type-specific intracellular bacteria, Science, 368, 973, 10.1126/science.aay9189

Jin, 2019, Commensal microbiota promote lung cancer development via γδ T cells, Cell, 176, 998, 10.1016/j.cell.2018.12.040

Pushalkar, 2018, The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression, Cancer Discov, 8, 403, 10.1158/2159-8290.CD-17-1134

McAllister, 2019, The tumor microbiome in pancreatic cancer: bacteria and beyond, Cancer Cell, 36, 577, 10.1016/j.ccell.2019.11.004

Kadosh, 2020, The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic, Nature, 586, 133, 10.1038/s41586-020-2541-0

Birch, 2020, Senescence and the SASP: many therapeutic avenues, Genes Dev, 34, 1565, 10.1101/gad.343129.120

Faget, 2019, Unmasking senescence: context-dependent effects of SASP in cancer, Nat Rev Cancer, 19, 439, 10.1038/s41568-019-0156-2

Gorgoulis, 2019, Cellular senescence: defining a path forward, Cell, 179, 813, 10.1016/j.cell.2019.10.005

He, 2017, Senescence in health and disease, Cell, 169, 1000, 10.1016/j.cell.2017.05.015

Kowald, 2020, On the evolution of cellular senescence, Aging Cell, 19, e13270, 10.1111/acel.13270

Lee, 2019, The dynamic nature of senescence in cancer, Nat Cell Biol, 21, 94, 10.1038/s41556-018-0249-2

Wang, 2020, Senescent cells in cancer therapy: friends or foes?, Trends Cancer, 6, 838, 10.1016/j.trecan.2020.05.004

Baker, 2016, Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan, Nature, 530, 184, 10.1038/nature16932

Ruhland, 2016, Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis, Nat Commun, 7, 11762, 10.1038/ncomms11762

Hwang, 2020, Endothelial cells under therapy-induced senescence secrete CXCL11, which increases aggressiveness of breast cancer cells, Cancer Lett, 490, 100, 10.1016/j.canlet.2020.06.019

Wang, 2020, Sunitinib facilitates metastatic breast cancer spreading by inducing endothelial cell senescence, Breast Cancer Res, 22, 103, 10.1186/s13058-020-01346-y

Amor, 2020, Senolytic CAR T cells reverse senescence-associated pathologies, Nature, 583, 127, 10.1038/s41586-020-2403-9

Aster, 2017, The varied roles of notch in cancer, Annu Rev Pathol, 12, 245, 10.1146/annurev-pathol-052016-100127

Kuczynski, 2019, Vessel co-option in cancer, Nat Rev Clin Oncol, 16, 469, 10.1038/s41571-019-0181-9